Showing results (1901-1910 of 3,530) with videos related to
Sort By:
Pageof 353
Thoracic Cancer|October 25, 2022
Early recurrence factors in patients with stage III non-small cell lung cancer treated with concurrent chemoradiotherapyYutaka Takahara, Takuya Tanaka, Yoko Ishige, et al.Thoracic Cancer|November 1, 2022
Modifying factors of PD-L1 expression on tumor cells in advanced non-small-cell lung cancerAlejandro Avilés-Salas, Diana Flores-Estrada, Luis Lara-Mejía, et al.Thoracic Cancer|October 24, 2022
Investigation of poor predictive factors in extensive stage small cell lung cancer under etoposide-platinum-atezolizumab treatmentJeong Uk Lim, Hye Seon Kang, Ah Young Shin, et al.Thoracic Cancer|October 24, 2022
An exploration of LAF-bTMB as a predictor for the efficacy of immunotherapy combined with chemotherapy in non-small cell lung cancerShuyang Zhang, Lu Yang, Yaning Yang, et al.Thoracic Cancer|October 5, 2022
Controversial role of mast cells in NSCLC tumor progression and angiogenesisVito Longo, Annamaria Catino, MIchele Montrone, et al.Thoracic Cancer|September 30, 2022
Coronavirus disease 2019 (COVID-19) in patients before, during, or after lung irradiation, and serum SP-A and SP-D levelsNaoya Ishibashi, Toshiya Maebayashi, Takuya Aizawa, et al.Thoracic Cancer|October 4, 2022
Clinicopathological analysis of a superior sulcus tumor treated by salvage surgery after concurrent definitive chemoradiotherapy followed by durvalumab: A case reportSoichiro Funaki, Naoko Ose, Toru Kimura, et al.Thoracic Cancer|October 4, 2022
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signalingJing Wang, Shuanghui Li, Xiujuan Zhang, et al.Thoracic Cancer|September 8, 2022
A case of cytokine release syndrome accompanied with COVID-19 infection during treatment with immune checkpoint inhibitors for non-small cell lung cancerDaiki Murata, Koichi Azuma, Saeko Tokisawa, et al.Thoracic Cancer|October 11, 2022
Long-term survival analysis of patients with stage IIIB-IV non-small cell lung cancer complicated by type 2 diabetes mellitus: A retrospective propensity score matching analysisXuejiao Li, Haiyan Fang, Dongwei Zhang, et al.Pageof 353